All six RTK ORFs were subcloned into the Gateway destination vector pEF5/FRT/V5-DEST (Invitrogen) using the LR reaction (Invitrogen). Destination vectors were cotransfected with accessory plasmid pOG44 (Invitrogen) into Flp-In-293 cells (Invitrogen) in the absence of antibiotics. After 48 h, cell were treated with trypsin and seeded at lower density. Hygromycin B selection (150 µg/mL) was then initiated to select for successful integration of the RTK ORFs into the host cell genome. Colonies appeared after several 3 weeks of selection and stable cell lines were established for each RTK by further expansion of pooled colonies. Expression levels of the RTKs were determined using ELISA kits from
Invitrogen for EGFR and Met, and from R&D Systems (Minneapolis, MN) for NTRK2 and PDGFRβ.
Cell culture and stimulations
Cells were maintained in Dulbecco's Modified Eagle Medium (DMEM; Mediatech, Herndon, VA) supplemented with 10% (v/v) Foetal Bovine Serum (FBS; Hyclone, Logan, UT), 2 mM Glutamine, 100 I.U./mL Penicillin, 100 µg/mL Streptomycin, and 150 µg/mL Hygromycin B. For experiments in which cells were stimulated with saturating concentrations of growth factor, 3 × 10 6 cells were seeded onto 15 cm D-lysine coated dishes. After 48 h, the cells were serum-starved for 24 h and stimulated for 5 min with the lowest concentration of growth factor that resulted in maximal receptor phosphorylation: 12 nM EGF, 16 nM aFGF, 12 nM IGF1, 12 nM HGF, 4 nM BDNF, and 8 nM PDGF-BB (Supplementary Figure 6) . In parallel, the transfected cell lines, as well as the parental Flp-In-293 cell line, were mocktreated with serum-free DMEM for 5 min. Cells were washed twice with cold PBS and 1.5 mL of lysis buffer was added to each dish.
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For the PI3K inhibition experiments, a dose-response curve was generated for the PI3K inhibitor LY294002 (BIOMOL International, L.P., Plymouth Meeting, PA) using the PDGFRβ-expressing cell line. Cells were pre-treated for 30 min with 12 concentrations of LY294002 and then stimulated for 5 min with 8 nM PDGF-BB. LY294002 activity was assessed by monitoring pSer473-Akt levels by immunoblotting. Complete inhibition was observed at a concentration of 100 µM. In subsequent experiments, cells were pre-treated for 30 min with 100 µM LY294002 in DMSO (0.2% v/v in final solution) or with DMSO alone and then stimulated for 5 min with the appropriate growth factor. Cells were washed twice with cold PBS and lysed as above.
Immunoblotting
Prior to immunoblotting, lysates were cleared by centrifugation at 20,000 g, 15 min, 4 °C and the total protein concentration was determined using the MicroBCA Protein Assay (Pierce Biotechnology, Rockford, IL). Lysates were boiled in standard SDS loading buffer and loaded onto 8, 10, or 12% polyacrylamide gels (10 µL lysate per lane). After separation by electrophoresis, the proteins were transferred to nitrocellulose and the membranes were blocked with 5% nonfat dry milk (w/v) in Tris-buffered saline (20 mM Tris, 150 mM NaCl, pH 7.6) containing 0.1% . Membranes were probed using rabbit-derived primary antibodies from Cell Signaling Technologies (Beverly, MA; Supplementary Table   1) . Bands were detected with IRDye 680-labelled goat-anti-rabbit IgG (LI-COR Biosciences, Lincoln, NE) and imaged using an Odyssey Infrared Imaging System (LI-COR Biosciences).
The intensity of each band was quantified and then normalized based on the protein concentration of the lysate. Relative phosphorylation levels were calculated for each phosphoprotein by first subtracting the level observed in the mock-treated, parental Flp-In-293 cell line and then dividing each value by the maximum observed value across the six cell lines. The reported relative levels are the average of two biological replicates.
Peptide synthesis and purification
Peptides were synthesized at 2 µmol scale in a 96-well plate with an Intavis MultiPep synthesizer (Koeln, Germany) using standard Fmoc chemistry. Pre-loaded NovaSyn TGT resin was from Novabiochem (San Diego, CA). Fmoc-protected amino acids were activated in situ with HBTU/N-methylmorpholine and coupled at 5-fold molar excess over peptide.
Each coupling cycle was followed by capping with acetic anhydride to avoid accumulation of one-residue deletion peptide by-products. At the end of the synthesis, peptides were labelled on the resin with 5-(and-6)-carboxytetramethylrhodamine [5(6)-TAMRA] from Anaspec (San Jose, CA). 5(6)-TAMRA was coupled using HATU/Diisopropylethylamine at a 7-fold molar excess over peptide. After labelling, the peptides were deprotected and cleaved from the resin with 95% trifluoroacetic acid, 2.5% triisopropylsilane, 2.5% ddH 2 O. The peptides were then precipitated by addition of cold diethylether.
Crude peptides were purified by reversed phase HPLC using a Kromasil 100-5-C18
semipreparative column (Peeke Scientific, Sunnyvale, CA). Fractions containing the correct product were identified by MALDI-TOF mass spectrometry using a Voyager DE Pro (Applied Biosystems, Foster City, CA). Solvent was removed by lyophilization and the purified peptides were stored at -80 °C.
Production and purification of recombinant proteins
The cloning of coding regions for SH2 and PTB domains has previously been described (Jones et al, 2006) . The cloning of coding regions for the amino terminal fragments of Stat1, Stat2, and Cbl has also previously been described (Kaushansky et al, 2008 
Scanning and analysis of microarrays
Protein microarrays were scanned at 10 µm resolution using a Tecan LS400 microarray scanner (Tecan, Salzburg, Austria). Cyanine-5 fluorescence was imaged using a 633 nm Table 4 ).
Partial least-squares regression (PLSR)
To define the receptor docking affinity matrix, X , the matrix of D K values (Supplementary 
and each receptor was defined as the sum of its constituent phosphopeptide vectors:
The raw receptor docking affinity matrix, raw X , was then assembled from the six receptor vectors:
The raw matrix was adjusted such that every SH2/PTB protein (i.e., every column) was mean-centred and weighted according to its average affinity. This yielded the final receptor docking affinity matrix, X . For the models presented in Figure 3 , proteins which bound fewer than five receptors were removed from the matrix. Models obtained using all of the data or increasingly smaller subsets are shown in Supplementary Figure 10 .
Relative phosphorylation levels of signalling proteins, as measured by immunoblotting, were calculated as described above and each phosphorylation site was treated as a separate vector, y , and each y was mean-centred and variance-normalized. A partial least-squares regression (Geladi and Kowalski, 1986) was then performed separately on each y . Briefly, a nonlinear iterative partial least squares (NIPALS) algorithm was used which decomposes the matrix X into a sum of outer products:
where i t , the scores vectors, represent dimensions in the orthogonal basis sets for the column space, and i p , the loading vectors, represent dimensions in the orthogonal basis sets for the 9 row space. This algorithm essentially computes the singular value decomposition (SVD) of the matrix:
where each t is equivalent to a column of the product Σ U , and each p is equivalent to a column of V . The NIPALS algorithm was used to define a vector w which maximizes the following:
The loading vector was then calculated by the newly rotated scores vector:
The coefficient b for the inner relation was defined as:
The vectors t and w are associated with the maximum eigenvalue of the covariance matrix, and once defined were removed from X and y to create a new residual matrix, i X , and vector, i y , which were used to define the next set of t , w , and p :
The vectors t , w , and p then formed the columns of T , W , and P , and i b formed the diagonal elements of B .
The vector y is implicitly a function of X . The explicit relation of the original X matrix to y can be calculated according to equation (12):
where c is a vector of the cumulative components of C :
Each w of the cross-validated data had a low variance up to four components, so the cumulative c of four components was used for the final models.
For cross-validation, each receptor (row "i") was removed once from both X and y , the regression was performed, and the resulting model was used to predict the value of i y .
The residual, Q 2 , of this prediction was then compared to residuals generated from randomly shuffling X 2000 times. The distribution of these residuals was used to calculate the P-value of the observed Q 2 .
The weighted sum of squares (also known as the variable importance in projection, VIP) for each variable, k, was calculated according to equation (14):
where T K is the total number of variables, a is the principal component, and a SS is the sum of squares for that component.
Amino acid frequencies near sites of tyrosine phosphorylation
Experimentally-determined sites of tyrosine phosphorylation in human proteins were acquired from the Phospho.Elm Database (Diella et al, 2008) . Of the 1397 identified sites, 196 were in RTKs and 1201 were in proteins other than RTKs. The amino acid frequencies at positions upstream and downstream of pTyr sites were calculated and then normalized to the expected frequency of each amino acid in all human proteins (Echols et al, 2002) . The resulting histograms of observed/expected frequencies were fit to a log-normal distribution and P-values were calculated based on these fits. The normalized amino acid frequencies observed in the set of proteins that excluded the RTKs had a random distribution centred near one with a narrow variance. In contrast, the amino acid frequencies observed in the RTKs had 11 a distribution with a much longer tail. The amino acids and positions of these high-frequency residues are highlighted in Figure 5 . The prevalence of Cys at positions -5 and +6 and the prevalence of Trp at position +7 is likely due to the conservation of structurally-importance residues in the kinase domain. Several RTKs have phosphorylated tyrosines in their kinase domain, and the over-represented Cys and Trp residues are associated with these tyrosines. In addition to these structurally-conserved residues, the following high-frequency residues were observed in RTKs: Asn at position -3, Pro at position -2, Asp at position +2, and Met at position +3. The sequence NPXpY is the canonical Shc1-binding motif and the sequence pYXDM is a commonly-observed PI3K-binding motif.
All analyses were performed using MATLAB 7.4. (Mathworks, Inc.). Each RTK-expressing cell line was serum-starved for 24 hours and stimulated with a saturating concentration of its cognate growth factor for 5 minutes. Lysate concentrations were normalized and protein phosphorylation levels were measured by quantitative immunoblotting. For each protein, basal phosphorylation in the untransfected parental cell line was subtracted and then its levels were scaled across the six cell lines relative to its maximum observed level, which was assigned a value of 1. Error bars indicate the range of biological duplicates. BLK  CRKL  ITK  PLCG2  SYK  VAV2  ABL1  CRK  E129946  GRB7  GULP1  NCK2  PIK3R1  PIK3R2  PIK3R3  SHB  SHC1  SRC  STAT1  STAT2  ZAP70  ANKS1  APBB1  BCAR3  DOK1  E138606  GRB10  LNK  LYN  PLCG1  PTPN6  SH2D3C   TNS  CBL  CTEN  E109111   FGR  IRS1  JAK2  JAK3  NUMBL  PTPN11   RIN1  SH2D3A   TEC  TENC1  TXK  APBB2  APBB3  BMX  DAB1  DOK2  DOK4  DOK5  DOK5L  EAT2  EB-1  GRAP2  GRB14  GRB2  NUMB  SH2B  SH2D2A  SH3BP2  SHC3  SLA2  TENS1  VAV1  VAV3  APBA3  APPL  EPS8L2   FES  HCK  HSH2D  IRS4  LCK  LCP2  NCK1  RABGAP1 Supplementary Figure 10 Residuals and significance values for models built using subsets of the microarray data. The cross-validated residual, Q 2 (A) and the P-value (B) are shown for models built using SH2/PTB domain-containing proteins that bound to at least 5 receptors, at least 4 receptors, at least 3 receptors, at least 2 receptors, and at least 1 receptor. Red and blue circles represent upstream and downstream phosphorylation events, respectively. 
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Upstream Signaling Events
Supplementary Figure 11
Performance and significance of PLSR models. PLSR models were tested using leave-one-out cross-validation. Predicted relative phosphorylation levels were plotted as a function of observed relative phosphorylation levels for upstream signaling events (A) and downstream signaling events (B). The cross-validated residual, Q 2 , and the P-value are shown for each model. Growth factor Growth factor + LY294002 Each of the six Flp-In-293-derived cell lines was serum-starved for 24 hours and pre-treated with the PI3K inhibitor LY294002 (100 µM) or mock-treated with DMSO for 30 minutes. The cells were then stimulated with a saturating concentration of growth factor for 5 minutes and relative protein phosphorylation levels were measured by quantitative immunoblotting. For each protein, basal phosphorylation in the untransfected parental cell line was subtracted and its levels were scaled across the six cell lines relative to its maximum observed level, which was assigned a value of 1. Error bars indicate the range of biological duplicates. Results for Src pY416 and Stat3 pY705 are shown in Figure 4 . 
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